Anna McCollister (@theannamc) 's Twitter Profile
Anna McCollister

@theannamc

Health IT Entrepreneur/advocate for innovation in patient-driven research, analytics, medical devices, interoperability & outcomes measures. T1 Diabetes patient

ID: 22931050

calendar_today05-03-2009 15:25:14

3,3K Tweet

1,1K Followers

455 Following

Scott Gottlieb, MD 🇺🇸 (@scottgottliebmd) 's Twitter Profile Photo

My op-ed on the large shift of drug discovery moving to China and policy steps the U.S. can take to keep the innovation economy in America. "Five years ago, U.S. drug makers didn’t license any new drugs from China. By 2024, 1/3 came from Chinese biotech" statnews.com/2025/05/06/how…

Isaac Kohane (@zakkohane) 's Twitter Profile Photo

AI to treat rare diseases: New contest announced at #SAIL2025 by Sam Finlayson UW Medicine working with UDN Harvard Medical School for multidisciplinary teams passionate for using ML for clinical impact. More details to appear soon at the link in the reply:

AI to  treat rare diseases: New contest announced at #SAIL2025 by <a href="/IAmSamFin/">Sam Finlayson</a> <a href="/UWMedicine/">UW Medicine</a> working with <a href="/UDNconnect/">UDN</a> <a href="/harvardmed/">Harvard Medical School</a> for multidisciplinary teams passionate for using ML for clinical impact. More details to appear soon at the link in the reply:
Scott Gottlieb, MD 🇺🇸 (@scottgottliebmd) 's Twitter Profile Photo

Another window into points I made in this op ed yesterday, about Chinese biotech displacing U.S. innovation: China’s share of clinical trial starts dramatically increased — from 1% to 30% over last decade, and Chinese biotech companies are poised to overtake U.S. counterparts

Another window into points I made in this op ed yesterday, about Chinese biotech displacing U.S. innovation: 
China’s share of clinical trial starts dramatically increased — from 1% to 30% over last decade, and Chinese biotech companies are poised to overtake U.S. counterparts
Voödoo 6 von Inyanga (@6voodoo) 's Twitter Profile Photo

Sometimes we try something, and it fails. The dumb pout, the smart learn. One never knows where that lesson will lead. Years or decades later it might come back into play, and might serve you and your people again. Like the Soviet Space Program and the Battle of Katya Roof.

Sometimes we try something, and it fails. The dumb pout, the smart learn. One never knows where that lesson will lead. Years or decades later it might come back into play, and might serve you and your people again. Like the Soviet Space Program and the Battle of Katya Roof.
Anna McCollister (@theannamc) 's Twitter Profile Photo

Very inspiring and motivating morning HHS.gov at the CMSGov #ASTP #ONC listening session for the health tech ecosystem RFI. I’m eager to see how Dr. Mehmet Oz & Amy Gleason lead transformation for #patients

Very inspiring and motivating morning <a href="/HHSGov/">HHS.gov</a> at the <a href="/CMSGov/">CMSGov</a> #ASTP #ONC listening session for the health tech ecosystem RFI. I’m eager to see how <a href="/DrOz/">Dr. Mehmet Oz</a> &amp; <a href="/ThePatientsSide/">Amy Gleason</a> lead transformation for #patients
Anna McCollister (@theannamc) 's Twitter Profile Photo

Another brilliant panel at the CMSGov listening session. kristen☾ from Be.well is crushing g it! Shares incredible story re absurd process issues Johns Hopkins University hosp when facing emergency. This is EXACTLY what we’re solving for The Sequoia Project consumer wkgp-THIS IS FIXABLE!

Another brilliant panel at the <a href="/CMSGov/">CMSGov</a> listening session. <a href="/kristenvaldes/">kristen☾</a> from Be.well is crushing g it! Shares incredible story re absurd process issues <a href="/JohnsHopkins/">Johns Hopkins University</a> hosp when facing emergency. This is EXACTLY what we’re solving for <a href="/sequoiaproject/">The Sequoia Project</a> consumer wkgp-THIS IS FIXABLE!
Anna McCollister (@theannamc) 's Twitter Profile Photo

It was encouraging & invigorating to see the leaders of the federal health agencies at Tuesday’s CMS mtg! Too much policy is focused on the needs of “the system” rather than people/patients who want health! Kudos Amy Gleason for her leadership & continuing 2 push for change!

It was encouraging &amp; invigorating to see the leaders of the federal health agencies at Tuesday’s CMS mtg! Too much policy is focused on the needs of “the system” rather than people/patients who want health! Kudos <a href="/ThePatientsSide/">Amy Gleason</a> for her leadership &amp; continuing 2 push for change!
Anna McCollister (@theannamc) 's Twitter Profile Photo

Sigh… does anybody from the #DOC #WeAreNotWaiting peeps (if any are still on twitter) have any idea why this is still happening? I’m looping w/ auto bolus. I’m now running “sick day” basal. I’ve had very few carbs. Not much fat. I’m not sick. Not stressed. 🤷🏼‍♀️😡 #T1D #diabetes

Sigh… does anybody from the #DOC  #WeAreNotWaiting peeps (if any are still on twitter) have any idea why this is still happening? I’m looping w/ auto bolus. I’m now running “sick day” basal.  I’ve had very few carbs. Not much fat. I’m not sick. Not stressed. 🤷🏼‍♀️😡 #T1D #diabetes
Ethan Mollick (@emollick) 's Twitter Profile Photo

👀Using an autonomous agent based on o3-mini and GPT-4.1, a team from Harvard, MIT & other institutions reproduced and updated an entire issue of Cochrane Reviews in two days… saving 12 person-years of work! The AI reviews captured more papers & were more accurate than humans.

👀Using an autonomous agent based on o3-mini and GPT-4.1, a team from Harvard, MIT &amp; other institutions reproduced and updated an entire issue of Cochrane Reviews in two days… saving 12 person-years of work!

The AI reviews captured more papers &amp; were more accurate than humans.
Anna McCollister (@theannamc) 's Twitter Profile Photo

I’m so devastated to hear of the death of Atul Butte he was brilliant, kind, supportive, funny & enthusiastic. I was honored to share the stage/podium w/ him a couple times, & his praise & support were beyond uplifting! This is a huge loss, because his life was so impactful.#RIP

Breakthrough T1D (@breakthrought1d) 's Twitter Profile Photo

Earlier today at the ADA Scientific Sessions, Sana Biotechnology gave an exciting 6-month update on the first person who received transplanted donor-derived pancreatic islet cells modified with hypo-immune (HIP) technology, a cell therapy that does NOT require immunosuppression.

Jan Oldenburg ☮️ (@janoldenburg) 's Twitter Profile Photo

This why people hate health insurers (with significant justification)! It is unreasonable and unjust to give people in the middle of treatment for cancer with less than 2 weeks to find alternatives.

Mark Cuban (@mcuban) 's Twitter Profile Photo

Yes and no. It comes down to the morals and patriotism of the CEO and board. They can accept less profits , and ask shareholders to increase the P/E they will accept, because it's the right thing to do for the country. You would be shocked at how many CEOs actually think this

Andrew D. Huberman, Ph.D. (@hubermanlab) 's Twitter Profile Photo

Remember that “I told you so” is a cynics path to failure. Let’s go with “awesome the trad media is catching on (to the DATA)!” Be nice mitochondriacs! The future of humanity depends on sharing what works not punishing those that were slow to arrive at the dance. Circadian rules.

Remember that “I told you so” is a cynics path to failure. Let’s go with “awesome the trad media is catching on (to the DATA)!”
Be nice mitochondriacs! The future of humanity depends on sharing what works not punishing those that were slow to arrive at the dance. Circadian rules.
Josh Mandel, MD (@joshcmandel) 's Twitter Profile Photo

The Prior Auth API is a Trap! The Da Vinci DTR Implementation Guide aims to reduce prior authorization friction by standardizing the format for asking and answering clinical questions. It is a well-engineered specification for a "computable clipboard," a significant improvement

Peter H. Diamandis, MD (@peterdiamandis) 's Twitter Profile Photo

I’m looking for “Research Fellows” to join my team and support my work in Abundance, AI and Longevity. These Fellow positions are entry-level, a way for you to work with me and my team. If interested apply here: Diamandis.com/research-fellow

I’m looking for “Research Fellows” to join my team and support my work in Abundance, AI and Longevity.  These Fellow positions are entry-level, a way for you to work with me and my team. If interested apply here: Diamandis.com/research-fellow